Citryll Bv
Clinical trials sponsored by Citryll Bv, explained in plain language.
-
New arthritis drug shows promise in early testing
Disease control Recruiting nowThis study is testing whether an experimental drug called CIT-013 can reduce symptoms in adults with moderately active rheumatoid arthritis. Participants will receive injections every other week for 6 weeks, with some receiving the drug and others receiving a placebo for comparis…
Phase: PHASE2 • Sponsor: Citryll BV • Aim: Disease control
Last updated Apr 04, 2026 04:50 UTC
-
New injection shows promise for painful skin condition
Disease control Recruiting nowThis study is testing whether an experimental drug called CIT-013 can reduce symptoms of hidradenitis suppurativa, a chronic inflammatory skin disease that causes painful lumps under the skin. 96 adults with moderate-to-severe HS who haven't responded well to antibiotics will rec…
Phase: PHASE2 • Sponsor: Citryll BV • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Scientists use PET scans to watch arthritis drug travel through Patients' bodies
Knowledge-focused Recruiting nowThis study aims to see where an experimental drug called CIT-013 goes in the body of people with inflammatory diseases like rheumatoid arthritis. Researchers will give patients a small, traceable amount of the drug and use PET-CT scans to track its movement to different organs an…
Phase: PHASE2 • Sponsor: Citryll BV • Aim: Knowledge-focused
Last updated Mar 02, 2026 15:26 UTC